Drug Trial Radar · NCT05641688
[18F]PI-2620 Phase 3 Histopathological Study
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Dec 1, 2022
Primary completion
Mar 2028
Study completion Sep 2028
Sponsor
- Lead sponsor
- Lantheus Biosciences Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.
Conditions
- Alzheimer Disease
Interventions
[18F]PI-2620Drug
The radioligand, \[18F\]PI-2620, will be injected intravenously at a dose of 185 MBq ± 20%
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic Efficacy of the visual assessment of [18F]PI-2620 PET imaging, in correctly differentiating tau neurofibrillary pathology associated with AD (NFT Score of B0 or B1 = negative)Time frame: At autopsy, until study completion with an average of 1 year
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona · Recruiting
Banner Sun Health Research Institute
Sun City, Arizona · Recruiting
UC Los Angeles
Los Angeles, California · Recruiting
Esperanza Clinical
Murrieta, California · Recruiting
Sutter Health
San Francisco, California · Recruiting
Galiz Research
Hialeah, Florida · Recruiting
UF College of Medicine - Jacksonville
Jacksonville, Florida · Withdrawn
K2 Medical Research
Lady Lake, Florida · Recruiting
K2 Medical Research
Maitland, Florida · Recruiting
ClinCloud Research
Melbourne, Florida · Recruiting
Miami Jewish Health Systems
Miami, Florida · Recruiting
The Roskamp Institute
Sarasota, Florida · Terminated
Charter Research
Winter Park, Florida · Recruiting
Alzheimer's Disease Center
Braintree, Massachusetts · Recruiting
Headlands Research
Plymouth, Massachusetts · Withdrawn
Be Well Clinical Studies
Lincoln, Nebraska · Withdrawn
Darthmouth-Hitchcock Medical Center
Lebanon, New Hampshire · Terminated
Velocity Clinical Research
East Syracuse, New York · Terminated
Ichor Research
Syracuse, New York · Recruiting
American Carolina Clinical Research LLC
Charlotte, North Carolina · Terminated
Insight Clinical Trials LLC
Beachwood, Ohio · Recruiting
Valley Medical Research
Centerville, Ohio · Recruiting
Baylor Research Institute
Dallas, Texas · Recruiting
Sante Clinical Research
Kerrville, Texas · Recruiting
Be Well Clinical Studies
Round Rock, Texas · Terminated
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.